Metformin significantly inhibits the growth of some cancer cells like breast, lung and hematologic cancers through the activation of AMPK with mammalian target of rapamycin (mTOR) or metabolic pathways (Zakikhani et al., 2006 ; Faubert et al., 2013). This evidence concerns the gene MTOR and cancer.